Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy
Abdul Rashid Issahaku, Namutula Mukelabai, Clement Agoni, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 151
Dual synergistic inhibition of COX and LOX by potential chemicals from Indian daily spices investigated through detailed computational studies
Mithun Rudrapal, Wafa Ali Eltayb, Gourav Rakshit, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 86
Synthesis of novel carbazole hydrazine-carbothioamide scaffold as potent antioxidant, anticancer and antimicrobial agents
İrfan Çapan, Mohammed Hawash, Mohammed T. Qaoud, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 24
Discovery of Potential KRAS‐SOS1 Inhibitors from South African Natural Compounds: An In silico Approach
Abdul Rashid Issahaku, Elliasu Y. Salifu, Clement Agoni, et al.
ChemistrySelect (2023) Vol. 8, Iss. 24
Closed Access | Times Cited: 34
Utilizing Andrographis paniculata leaves and roots by effective usage of the bioactive andrographolide and its nanodelivery: investigation of antikindling and antioxidant activities through in silico and in vivo studies
Ramana Baru Venkata, Dintakurthi Sree Naga Bala Krishna Prasanth, Praveen Kumar Pasala, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 31
Comparison of new secondgeneration H1 receptor blockers with some molecules; a study involving DFT, molecular docking, ADMET, biological target and activity
Velid Ünsal, Erkan Öner, Reşit Yıldız, et al.
BMC Chemistry (2025) Vol. 19, Iss. 1
Open Access | Times Cited: 1
In vitro biological evaluation and in silico insights into the antiviral activity of standardized olive leaves extract against SARS-CoV-2
Taghreed A. Majrashi, Mahmoud A. El Hassab, Sara H. Mahmoud, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0301086-e0301086
Open Access | Times Cited: 5
Identification and affinity enhancement of T-cell receptor targeting a KRASG12V cancer neoantigen
Mengyu Zhang, Wei Xu, Lingjie Luo, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 5
Pathways and mechanism of MRTX1133 binding to KRAS G12D elucidated by molecular dynamics simulations and Markov state models
Gao Tu, Yaguo Gong, Xiaojun Yao, et al.
International Journal of Biological Macromolecules (2024) Vol. 274, pp. 133374-133374
Closed Access | Times Cited: 5
Discovery of natural products as influenza neuraminidase inhibitors: in silico screening, in vitro validation, and molecular dynamic simulation studies
Binglin Huang, Bijuan Lin, Hong Zheng, et al.
Molecular Diversity (2025)
Closed Access
In silico exploration of natural xanthone derivatives as potential inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication and cellular entry
Vincent A. Obakachi, Vaderament‐A. Nchiozem‐Ngnitedem, Krishna Govender, et al.
Journal of Computer-Aided Molecular Design (2025) Vol. 39, Iss. 1
Open Access
Molecular Docking, DFT and Dynamics Simulations of Jatropha curcas-Derived Compounds Targeting PR and hERα for Breast Cancer Treatment
Emmanuel Kitete Mulongo, Jason Kilembe Thambwe, N Y, et al.
Next research. (2025), pp. 100249-100249
Closed Access
Uncovering the Effects and Molecular Mechanisms of Shaoyao Decoction Against Colorectal Cancer Using Network Pharmacology Analysis Coupled With Experimental Validation and Gut Microbiota Analysis
Yuan Rong, Guiyu Zhang, Wenhao Ye, et al.
Cancer Medicine (2025) Vol. 14, Iss. 6
Open Access
Targeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
Rima Hajjo, Dima A. Sabbah, Sanaa K. Bardaweel, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 1-2, pp. 51-69
Closed Access | Times Cited: 4
Unveiling the Antiophidian Potential of Epicatechin and Isoquercetin from Tapinanthus globiferus growing on Acacia nilotica: An In silico and In vitro Studies
A. J. Yusuf, Musa Sadiq, Aisha Iliyasu Bugaje, et al.
Pharmacological Research - Natural Products (2025), pp. 100197-100197
Closed Access
Evolution of computational techniques against various KRAS mutants in search for therapeutic drugs: a review article
Asif Mehmood, Mohammed Ageeli Hakami, Hanan A. Ogaly, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Closed Access
Multi-dimensional structural footprint identification for the design of potential scaffolds targeting METTL3 in cancer treatment from natural compounds
Abdul Rashid Issahaku, Samukelisiwe Minenhle Mncube, Clement Agoni, et al.
Journal of Molecular Modeling (2023) Vol. 29, Iss. 4
Closed Access | Times Cited: 9
Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations
Basma M. Qandeel, Samar Mowafy, Khaled A.M. Abouzid, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 3
DFT and molecular simulation validation of the binding activity of PDEδ inhibitors for repression of oncogenic k-Ras
Taghreed A. Majrashi, Ahmed Sabt, Hadia Almahli, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0300035-e0300035
Open Access | Times Cited: 3
In Silico and In Vitro Screening of Some Pregnane Glycosides Isolated from Certain Caralluma Species as SARS‐COV‐2 Main Protease Inhibitors
Essam Abdel‐Sattar, Omnia Kutkat, Riham A. El‐Shiekh, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 4
Closed Access | Times Cited: 3
Molecular dynamics simulations for the structure-based drug design: targeting small-GTPases proteins
Angela Parise, Sofia Cresca, Alessandra Magistrato
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 10, pp. 1259-1279
Closed Access | Times Cited: 3
In silico identification of potential inhibitors of acyl carrier protein reductase and acetyl CoA carboxylase of Plasmodium falciparum in antimalarial therapy
Elliasu Y. Salifu, James Abugri, Abdul Rashid Issahaku, et al.
Frontiers in Drug Discovery (2023) Vol. 3
Open Access | Times Cited: 8
Intermolecular And Dynamic Investigation of The Mechanism of Action of Reldesemtiv on Fast Skeletal Muscle Troponin Complex Toward the Treatment of Impaired Muscle Function
Abdul Rashid Issahaku, Mahmoud A. A. Ibrahim, Namutula Mukelabai, et al.
The Protein Journal (2023) Vol. 42, Iss. 4, pp. 263-275
Open Access | Times Cited: 8
Site-specific mutagenesis screening in KRAS mutant library to uncover resistance mechanisms to KRASG12D inhibitors
Jeesoo Choi, J. H. Shin, Taeyul K. Kim, et al.
Cancer Letters (2024) Vol. 591, pp. 216904-216904
Closed Access | Times Cited: 2
Exploration of Type III effector Xanthomonas outer protein Q (XopQ) inhibitor from Picrasma quassioides as an antibacterial agent using chemoinformatics analysis
Prasanna D. Revanasiddappa, Hittanahallikoppal Gajendramurthy Gowtham, G. S. Chikkanna, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0302105-e0302105
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top